Similar articles for PMID: 16556865

Year	Number of Results
1997	2
1998	4
1999	2
2000	3
2001	10
2002	9
2003	14
2004	20
2005	24
2006	24
2007	25
2008	24
2009	27
2010	26
2011	20
2012	22
2013	31
2014	32
2015	21
2016	20
2017	29
2018	28
2019	17
2020	32
2021	22
2022	17
2023	8
2024	0

1

Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.

Shamgar L, Ma L, Schmitt N, Haitin Y, Peretz A, Wiener R, Hirsch J, Pongs O, Attali B. Shamgar L, et al. Circ Res. 2006 Apr 28;98(8):1055-63. doi: 10.1161/01.RES.0000218979.40770.69. Epub 2006 Mar 23. Circ Res. 2006. PMID: 16556865

2

Functional effects of a KCNQ1 mutation associated with the long QT syndrome.

Boulet IR, Raes AL, Ottschytsch N, Snyders DJ. Boulet IR, et al. Cardiovasc Res. 2006 Jun 1;70(3):466-74. doi: 10.1016/j.cardiores.2006.02.006. Epub 2006 Feb 28. Cardiovasc Res. 2006. PMID: 16564513

3

Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.

Deschênes D, Acharfi S, Pouliot V, Hegele R, Krahn A, Daleau P, Chahine M. Deschênes D, et al. Can J Physiol Pharmacol. 2003 Feb;81(2):129-34. doi: 10.1139/y02-162. Can J Physiol Pharmacol. 2003. PMID: 12710526

4

LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.

Aromolaran AS, Subramanyam P, Chang DD, Kobertz WR, Colecraft HM. Aromolaran AS, et al. Cardiovasc Res. 2014 Dec 1;104(3):501-11. doi: 10.1093/cvr/cvu231. Epub 2014 Oct 24. Cardiovasc Res. 2014. PMID: 25344363 Free PMC article.

5

Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.

Ohno S, Toyoda F, Zankov DP, Yoshida H, Makiyama T, Tsuji K, Honda T, Obayashi K, Ueyama H, Shimizu W, Miyamoto Y, Kamakura S, Matsuura H, Kita T, Horie M. Ohno S, et al. Hum Mutat. 2009 Apr;30(4):557-63. doi: 10.1002/humu.20834. Hum Mutat. 2009. PMID: 19306396

6

Chronic probucol treatment decreases the slow component of the delayed-rectifier potassium current in CHO cells transfected with KCNQ1 and KCNE1: a novel mechanism of QT prolongation.

Taniguchi T, Uesugi M, Arai T, Yoshinaga T, Miyamoto N, Sawada K. Taniguchi T, et al. J Cardiovasc Pharmacol. 2012 Apr;59(4):377-86. doi: 10.1097/FJC.0b013e318245e0c5. J Cardiovasc Pharmacol. 2012. PMID: 22189896

7

Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.

El Harchi A, McPate MJ, Zhang YH, Zhang H, Hancox JC. El Harchi A, et al. J Physiol Pharmacol. 2010 Apr;61(2):123-31. J Physiol Pharmacol. 2010. PMID: 20436212 Free article.

8

The oxidant thimerosal modulates gating behavior of KCNQ1 by interaction with the channel outer shell.

Kerst G, Brousos H, Schreiber R, Nitschke R, Hug MJ, Greger R, Bleich M. Kerst G, et al. J Membr Biol. 2002 Mar 15;186(2):89-100. doi: 10.1007/s00232-001-0138-6. J Membr Biol. 2002. PMID: 11944086

9

Modulation of functional properties of KCNQ1 channel by association of KCNE1 and KCNE2.

Toyoda F, Ueyama H, Ding WG, Matsuura H. Toyoda F, et al. Biochem Biophys Res Commun. 2006 Jun 9;344(3):814-20. doi: 10.1016/j.bbrc.2006.03.213. Epub 2006 Apr 19. Biochem Biophys Res Commun. 2006. PMID: 16631607

10

Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).

Jow F, Tseng E, Maddox T, Shen R, Kowal D, Dunlop J, Mekonnen B, Wang K. Jow F, et al. Assay Drug Dev Technol. 2006 Aug;4(4):443-50. doi: 10.1089/adt.2006.4.443. Assay Drug Dev Technol. 2006. PMID: 16945016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

461 results

Results by year